Trial intelligence / Profile preview

FSH Role in PSA Induction in Castrated Men

NCT04134130Completed

Sponsor
Lund University
Start
Sep 2019
Primary completion
Dec 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of follitropin alfa in prostate cancer (PCa) (2 arms), sponsored by Lund University. Primary endpoint: Prostate Specific Antigen concentration at 5 weeks. Started Sep 2019; status: completed.

02

Drugs

follitropin alfa
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT04134130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04134130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call